Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New drug delivery methods can make natural compounds more effective and stable.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Blood tests confirmed a baby in the womb had a CMV infection.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

The document explains how to identify different hair problems using a microscope.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Finasteride and minoxidil together work best for male hair loss.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Ultrasound shows 80% of Hidradenitis Suppurativa patients have abnormal hair tracts that may worsen the condition.